Results 71 to 80 of about 209,696 (350)
Non-vitamin K antagonist oral anticoagulants in atrial fibrillation accompanying mitral stenosis: the concept for a trial. [PDF]
Patients at thromboembolic risk with non-valvular atrial fibrillation (AF) can now be managed either with a vitamin K antagonist (VKA) or with a fixed dose of a non-VKA oral anticoagulant (NOAC), while patients with valvular AF have been restricted to ...
De Caterina, R, John Camm, A
core +1 more source
A Streamline Strategy for Indication and Length of Telemetry Monitoring After TAVR
ABSTRACT Background Both indication and length of ECG telemetry monitoring (TM) after transcatheter aortic valve replacement (TAVR) are not well defined. Aims We hypothesize that a targeted strategy for monitoring conductive disorders (CD) post‐TAVR can reduce the need and duration of in‐hospital TM without compromising safety. Methods We prospectively
Antonin Fournier +13 more
wiley +1 more source
'Edge-to-edge' mitral valve repair: the ace of hearts [PDF]
A 32-year-old man underwent a successful surgical correction of a severe mitral regurgitation. The surgical procedure consisted of an ‘edge-to-edge’ repair of the valve, connecting the mid-portion of the anterior and posterior leaflets, associated with implantation of a mitral annuloplasty ring (Sovering O 38 mm; …
ZACÀ V. +3 more
openaire +4 more sources
ABSTRACT Transcatheter aortic valve implantation (TAVI) has become an established treatment for severe aortic stenosis. However, the need for unplanned conversion to cardiac surgery (CS) during TAVI remains an infrequent but critical event. It is unclear whether this risk is higher in patients undergoing urgent procedures.
Nikolaos Ktenopoulos +12 more
wiley +1 more source
A substituição da valva mitral tem sido realizada, nestes 30 anos, usando-se o modelo aórtico. Embora o resultado clínico, na maioria dos pacientes seja satisfatório, existem, restrições específicas, tanto entre as biopróteses, como nas próteses ...
Mário O Vrandecic +8 more
doaj
A Rare Culprit of Infective Endocarditis in an IV Drug User: Burkholderia cepacia
Infective endocarditis (IE) is an infection of the cardiac native or prosthetic valves typically caused by Staphylococcus aureus, viridans streptococci group, and coagulase-negative staphylococci. Risk factors include congenital heart disease, structural
Christopher Nnaoma +2 more
doaj +1 more source
Modelling mitral valvular dynamics–current trend and future directions [PDF]
Dysfunction of mitral valve causes morbidity and premature mortality and remains a leading medical problem worldwide. Computational modelling aims to understand the biomechanics of human mitral valve and could lead to the development of new treatment ...
Berry, Colin +6 more
core +1 more source
ABSTRACT Background Percutaneous mitral commissurotomy (PMC) of mitral stenosis is routinely performed by the Inoue balloon technique (IBT) which may be challenging with respect to valvular crossing. Using a novel wire‐assisted method (WAM) may improve feasibility and time efficiency. Aims In a randomized clinical trial, we compared the feasibility and
Chala Fekadu Oljira +11 more
wiley +1 more source
BackgroundValvular heart disease (VHD) is a leading cause of cardiovascular morbidity and mortality that poses a substantial health care and economic burden on health care systems.
Fagen Xie +5 more
doaj +1 more source
Dynamic three-dimensional reconstruction of the heart by transesophageal echocardiography
OBJECTIVE: To evaluate echocardiography accuracy in performing and obtaining images for dynamical three-dimensional (3D) reconstruction. METHODS: Three-dimensional (3D) image reconstruction was obtained in 20 consecutive patients who underwent ...
Maria de Fátima Veiga +2 more
doaj +1 more source

